(Q46301106)

21 December 2017

title

Clinical practice guidelines for gastrointestinal stromal tumor (GIST) in Japan: English version (English)

1 reference

21 December 2017

gastrointestinal stromal tumor

main subject

1 reference

Toshirou Nishida

1

1 reference

21 December 2017

Seiichi Hirota

2

1 reference

21 December 2017

Akio Yanagisawa

3

1 reference

21 December 2017

Yoshinori Sugino

4

1 reference

21 December 2017

Manabu Minami

5

1 reference

21 December 2017

Yoshitaka Yamamura

6

1 reference

21 December 2017

Yoshihide Otani

7

1 reference

21 December 2017

Yasuhiro Shimada

8

1 reference

21 December 2017

Fumiaki Takahashi

9

1 reference

21 December 2017

Tetsuro Kubota

10

1 reference

21 December 2017

GIST Guideline Subcommittee

11

1 reference

21 December 2017

publication date

23 October 2008

1 reference

21 December 2017

International Journal of Clinical Oncology

published in

1 reference

21 December 2017

volume

13

1 reference

21 December 2017

issue

5

1 reference

21 December 2017

page(s)

416-430

1 reference

21 December 2017

https://scigraph.springernature.com/pub.10.1007/s10147-008-0798-7

exact match

0 references

cites work

Gastrointestinal stromal tumors of the stomach: CT findings and prediction of malignancy.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10147-008-0798-7

CT evaluation of the response of gastrointestinal stromal tumors after imatinib mesylate treatment: a quantitative analysis correlated with FDG PET findings

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10147-008-0798-7

An enhanced risk-group stratification system for more practical prognostication of clinically malignant gastrointestinal stromal tumors

21 January 2018

1 reference

12 December 2020

Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival.

1 reference

12 December 2020

Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033.

1 reference

12 December 2020

KIT and platelet-derived growth factor receptor alpha tyrosine kinase gene mutations and KIT amplifications in human solid tumors

1 reference

12 December 2020

Gastrointestinal stromal tumor: consistent CD117 immunostaining for diagnosis, and prognostic classification based on tumor size and MIB-1 grade

1 reference

12 December 2020

Prospective multicentric randomized phase III study of imatinib in patients with advanced gastrointestinal stromal tumors comparing interruption versus continuation of treatment beyond 1 year: the French Sarcoma Group.

1 reference

12 December 2020

Molecular correlates of imatinib resistance in gastrointestinal stromal tumors.

1 reference

12 December 2020

Operative indications for relatively small (2-5 cm) gastrointestinal stromal tumor of the stomach based on analysis of 60 operated cases

1 reference

12 December 2020

Surgical strategy for gastric gastrointestinal stromal tumors: laparoscopic vs. open resection

1 reference

12 December 2020

NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)--update of the NCCN clinical practice guidelines.

1 reference

12 December 2020

Clinical management of gastrointestinal stromal tumors: before and after STI-571.

1 reference

12 December 2020

Endoscopic ultrasound-guided fine-needle aspiration biopsy: a powerful tool to obtain samples from small lesions

1 reference

12 December 2020

Surgery of residual disease following molecular-targeted therapy with imatinib mesylate in advanced/metastatic GIST.

1 reference

12 December 2020

Initial and late resistance to imatinib in advanced gastrointestinal stromal tumors are predicted by different prognostic factors: a European Organisation for Research and Treatment of Cancer-Italian Sarcoma Group-Australasian Gastrointestinal Trial

1 reference

12 December 2020

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

1 reference

12 December 2020

PDGFRA activating mutations in gastrointestinal stromal tumors.

1 reference

12 December 2020

Diagnosis of gastrointestinal stromal tumors: A consensus approach

1 reference

12 December 2020

Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial

1 reference

12 December 2020

Prognostic value of KIT mutation type, mitotic activity, and histologic subtype in gastrointestinal stromal tumors

1 reference

12 December 2020

Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor

1 reference

12 December 2020

Resection of residual disease in patients with metastatic gastrointestinal stromal tumors responding to treatment with imatinib.

1 reference

12 December 2020

Laparoscopic management of gastrointestinal stromal tumors

1 reference

12 December 2020

The role of 18F-FDG PET in staging and early prediction of response to therapy of recurrent gastrointestinal stromal tumors.

1 reference

12 December 2020

Surgical interventions for focal progression of advanced gastrointestinal stromal tumors during imatinib therapy.

1 reference

12 December 2020

PDGFRalpha- and c-kit-mutated gastrointestinal stromal tumours (GISTs) are characterized by distinctive histological and immunohistochemical features

1 reference

12 December 2020

Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors

1 reference

12 December 2020

Gastrointestinal stromal tumor (GIST) and imatinib

1 reference

12 December 2020

Long-term outcomes of laparoscopic resection of gastric gastrointestinal stromal tumors

1 reference

12 December 2020

Gastrointestinal stromal tumor. Correlation of computed tomography findings with tumor grade and mortality.

1 reference

12 December 2020

Surgical management of advanced gastrointestinal stromal tumors after treatment with targeted systemic therapy using kinase inhibitors

1 reference

12 December 2020

Comparison of PET, CT, and dual-modality PET/CT imaging for monitoring of imatinib (STI571) therapy in patients with gastrointestinal stromal tumors

1 reference

12 December 2020

Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO.

1 reference

12 December 2020

Surgical treatment of patients with initially inoperable and/or metastatic gastrointestinal stromal tumors (GIST) during therapy with imatinib mesylate

1 reference

12 December 2020

Immunohistochemical spectrum of GISTs at different sites and their differential diagnosis with a reference to CD117 (KIT)

1 reference

12 December 2020

Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial

1 reference

12 December 2020

Clinicopathologic study of primary malignant gastrointestinal stromal tumor of the stomach, with special reference to prognostic factors: analysis of results in 140 surgically resected patients

1 reference

12 December 2020

Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study

1 reference

12 December 2020

Gain-of-function mutations of platelet-derived growth factor receptor alpha gene in gastrointestinal stromal tumors.

1 reference

12 December 2020

Results of tyrosine kinase inhibitor therapy followed by surgical resection for metastatic gastrointestinal stromal tumor

1 reference

12 December 2020

Analysis of KIT mutations in sporadic and familial gastrointestinal stromal tumors: therapeutic implications through protein modeling

1 reference

12 December 2020

Gastrointestinal stromal tumor: new nodule-within-a-mass pattern of recurrence after partial response to imatinib mesylate

1 reference

12 December 2020

Outcome of patients with advanced gastro-intestinal stromal tumours crossing over to a daily imatinib dose of 800 mg after progression on 400 mg.

1 reference

12 December 2020

Lymph node metastasis from soft tissue sarcoma in adults. Analysis of data from a prospective database of 1772 sarcoma patients

1 reference

12 December 2020

10.1007/S10147-008-0798-7

Identifiers

DOI

1 reference

21 December 2017

PubMed ID

18946752

1 reference

21 December 2017